These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37581097)

  • 1. Anti-Vascular Endothelial Growth Factor Therapy with or Without Initial Steroid Therapy for Macular Edema in Branch Retinal Vein Occlusion.
    Noma H; Yasuda K; Nonaka R; Sasaki S; Shimura M
    Clin Ophthalmol; 2023; 17():2267-2275. PubMed ID: 37581097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Intravitreal Ranibizumab Injection on Peripheral Retinal Microcirculation and Cytokines in Branch Retinal Vein Occlusion with Macular Edema.
    Yasuda K; Noma H; Mimura T; Nonaka R; Sasaki S; Suganuma N; Shimura M
    Medicina (Kaunas); 2023 May; 59(6):. PubMed ID: 37374257
    [No Abstract]   [Full Text] [Related]  

  • 3. Change of cytokines after intravitreal ranibizumab in patients with recurrent branch retinal vein occlusion and macular edema.
    Noma H; Yasuda K; Shimura M
    Eur J Ophthalmol; 2021 Jan; 31(1):204-210. PubMed ID: 31690095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal Microcirculation and Cytokines as Predictors for Recurrence of Macular Edema after Intravitreal Ranibizumab Injection in Branch Retinal Vein Occlusion.
    Noma H; Yasuda K; Mimura T; Suganuma N; Shimura M
    J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ranibizumab on growth factors and mediators of inflammation in the aqueous humor of patients with diabetic macular edema.
    Utsumi T; Noma H; Yasuda K; Goto H; Shimura M
    Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2597-2603. PubMed ID: 33772356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of soluble vascular endothelial growth factor receptors-1 and -2, their ligands, and other factors in branch retinal vein occlusion with macular edema.
    Noma H; Mimura T; Yasuda K; Shimura M
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(6):3878-85. PubMed ID: 24894397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional-morphological parameters, aqueous flare and cytokines in macular oedema with branch retinal vein occlusion after ranibizumab.
    Noma H; Mimura T; Yasuda K; Shimura M
    Br J Ophthalmol; 2017 Feb; 101(2):180-185. PubMed ID: 27073207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of inflammation in previously untreated macular edema with branch retinal vein occlusion.
    Noma H; Mimura T; Shimada K
    BMC Ophthalmol; 2014 May; 14():67. PubMed ID: 24884703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion.
    Mashima A; Noma H; Yasuda K; Goto H; Shimura M
    J Inflamm (Lond); 2019; 16():9. PubMed ID: 31139023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-VEGF Therapy Reduces Inflammation in Diabetic Macular Edema.
    Imazeki M; Noma H; Yasuda K; Motohashi R; Goto H; Shimura M
    Ophthalmic Res; 2021; 64(1):43-49. PubMed ID: 32454504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal Ranibizumab and Aqueous Humor Factors/Cytokines in Major and Macular Branch Retinal Vein Occlusion.
    Noma H; Mimura T; Yasuda K; Nakagawa H; Motohashi R; Kotake O; Shimura M
    Ophthalmologica; 2016; 235(4):203-7. PubMed ID: 27003517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
    Sohn HJ; Han DH; Lee DY; Nam DH
    Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing Cytokine Kinetics between Ranibizumab and Aflibercept in Central Retinal Vein Occlusion with Macular Edema.
    Kotake O; Noma H; Yasuda K; Motohashi R; Goto H; Shimura M
    Ophthalmic Res; 2018 May; ():1-8. PubMed ID: 29804112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D; Bunce C; Charteris D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Shalchi Z; Mahroo O; Bunce C; Mitry D
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines and Recurrence of Macular Edema after Intravitreal Ranibizumab in Patients with Branch Retinal Vein Occlusion.
    Noma H; Mimura T; Yasuda K; Nakagawa H; Motohashi R; Kotake O; Shimura M
    Ophthalmologica; 2016; 236(4):228-234. PubMed ID: 27832655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema.
    Yu SY; Nam DH; Lee DY
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):39-47. PubMed ID: 29030692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema.
    Noma H; Mimura T; Yasuda K; Shimura M
    Ophthalmic Res; 2016; 56(4):207-214. PubMed ID: 27160159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conbercept improves macular microcirculation and retinal blood supply in the treatment of nonischemic branch retinal vein occlusion macular edema.
    Huang Y; Linghu M; Hu W; Huang X
    J Clin Lab Anal; 2022 Dec; 36(12):e24774. PubMed ID: 36408725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year results of anti-vascular endothelial growth factor therapy combined with triamcinolone acetonide for macular edema associated with branch retinal vein occlusion.
    Osaka R; Muraoka Y; Nakano Y; Takasago Y; Koyama Y; Miyoshi Y; Tsujikawa A; Suzuma K
    Jpn J Ophthalmol; 2020 Nov; 64(6):605-612. PubMed ID: 32856208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.